Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

SVR · NZX

Savor (SVR)

Consumer / Hospitality•Covered: HY21 - FY26•10 published briefings

Savor is an NZX-listed consumer / hospitality company with HY21 - FY26 of published result briefings.

Latest briefing

FY26 · Released 26 May 2026

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Market data

Latest available
Price
NZD 0.17
Mkt cap
$13.1m
Yield
0%

Quote as of 05-06-2026 3:30pm NZT

Sections⌄
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights
  1. Snapshot
  2. Chat
  3. Longitudinal View
  4. Follow-through
  5. Archive
  6. Related Insights

Snapshot

Latest metrics

FY26, released 26 May 2026

← Swipe to view more
SVR latest metrics
MetricValueChange
Revenue$55.2m↓ -2.6%
EBITDA$8m↑ +10.3%
NPAT$1.3m↑ +208.3%
Operating cash flow$6.9m↓ -3.2%
OCF / EBITDA %85.8%↓ -11.9pp
Net debt$6.3m↓ -12.2%
Net debt / EBITDA0.79xOutside range lowOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.↓ -20.2%
ROE %6.9%Outside range highOutside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.↑ +13.9pp
PBT$1.8m↑ +228.6%
FCF pre-lease$4.6m↓ -20.1%

Source: latest published briefing (FY26, released 26 May 2026). Change compares against the prior equivalent period: FY25, released 22 May 2025.

Chat

Ask about SVR

Ask follow-up questions about Savor's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SVR

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
SVR metric history
MetricFY2612 MONTHS26 May 2026FY2512 MONTHS22 May 2025FY2412 MONTHS22 May 2024HY246 MONTHS28 November 2023FY2312 MONTHS25 May 2023HY236 MONTHS23 November 2022FY2212 MONTHS27 May 2022HY226 MONTHS18 November 2021FY2112 MONTHS28 May 2021HY216 MONTHS27 November 2020Trend
Revenue$55.2m$56.6m$61.9m$29.1m$52.4m$20.7m$30.6m$17.2m$16.1m$9.9m
Chart
Revenue growth %-2.6%-8.4%18.1%40.4%180.2%Unprecedented highUnprecedented high revenue growth. 180.2%; 5-period range -57.8% to 89.5%. Revenue growth: 180.2%, unprecedented high; 5-period mean 7.8%, range -57.8%-89.5%.20.7%89.5%73.3%Outside range highOutside range high revenue growth. 73.3%; 3-period range -45% to 40.4%. Revenue growth: 73.3%, above normal range; 3-period mean 5.4%, range -45.0%-40.4%.-57.8%Outside range lowOutside range low revenue growth. -57.8%; 5-period range -8.4% to 180.2%. Revenue growth: -57.8%, below normal range; 5-period mean 55.4%, range -8.4%-180.2%.-45.0%Outside range lowOutside range low revenue growth. -45%; 3-period range 20.7% to 73.3%. Revenue growth: -45.0%, below normal range; 3-period mean 44.8%, range 20.7%-73.3%.
Chart
  • FY23 Revenue growth %: Unprecedented high revenue growth. 180.2%; 5-period range -57.8% to 89.5%. Revenue growth: 180.2%, unprecedented high; 5-period mean 7.8%, range -57.8%-89.5%.
EBITDA$8m$7.3m$8.8m$3.1m$5.2m$1.4m$3m$2.1m$1.8m$0.69m
Chart
EBITDA margin %14.5%Outside range highOutside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.12.8%14.2%10.7%10.0%6.8%Outside range lowOutside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.9.8%Outside range lowOutside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.12.3%Outside range highOutside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.11.4%6.9%
Chart
  • FY26 EBITDA margin %: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.
PBT$1.8m-$1.4m-$2.9m-$0.4m-$2.3m-$2.1m-$5m-$0.8m-$3.1m-$0.4m
Chart
NPAT$1.3m-$1.2m$0.7m-$0.4m-$2.3m-$2.1m-$5m-$0.8m-$6.6m-$0.4m
Chart
Operating cash flow$6.9m$7.1m$6.4m$2.5m$6.1m$1.6m$3m$1.1m$0.01m-$0.14m
Chart
OCF / EBITDA %85.8%97.7%73.0%81.8%116.2%Outside range highOutside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.117.3%Outside range highOutside range high ocf / ebitda cash conversion. 117.3%; 3-period range -20.8% to 81.8%. OCF / EBITDA cash conversion: 117.3%, above normal range; 3-period mean 38.2%, range -20.8%-81.8%.98.6%53.5%0.7%Unprecedented lowUnprecedented low ocf / ebitda cash conversion. 0.7%; 5-period range 73% to 116.2%. OCF / EBITDA cash conversion: 0.7%, unprecedented low; 5-period mean 94.3%, range 73.0%-116.2%.-20.8%
Chart
  • FY23 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.
FCF pre-lease$4.6m$5.8m$5.9m$2.2m$1.8m-$0.73m$1m-$0.03m-$1.3m-$0.56m
Chart
DPS—-9.0c-8.0c-11.0c-13.0c-16.0c-18.0c——16.0c
Chart
ROE %6.9%Outside range highOutside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.-7.0%3.6%-2.5%Outside range highOutside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.-13.5%-14.9%Outside range lowOutside range low roe. -14.9%; 3-period range -4% to -2.5%. ROE: -14.9%, below normal range; 3-period mean -3.0%, range -4.0%--2.5%.-35.1%Unprecedented lowUnprecedented low roe. -35.1%; 4-period range -13.5% to 6.9%. ROE: -35.1%, unprecedented low; 4-period mean -2.5%, range -13.5%-6.9%.-4.0%-51.9%-2.6%
Chart
  • HY24 ROE %: Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.
  • FY26 ROE %: Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.
Net debt$6.3m$7.2m$9.1m$13.7m$11.9m$13.8m$12.1m$11.5m$3.6m$5.2m
Chart
Net debt / EBITDA0.79xOutside range lowOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.0.99x1.03x4.41xOutside range lowOutside range low net debt / ebitda. 4.4x; 3-period range 5.45x to 9.8x. Net debt / EBITDA: 4.40x, below normal range; 3-period mean 7.60x, range 5.45x-9.80x.2.27x9.84xOutside range highOutside range high net debt / ebitda. 9.8x; 3-period range 4.4x to 7.55x. Net debt / EBITDA: 9.80x, above normal range; 3-period mean 5.80x, range 4.40x-7.55x.4.03xUnprecedented highUnprecedented high net debt / ebitda. 4.03x; 5-period range 0.79x to 2.3x. Net debt / EBITDA: 4.03x, unprecedented high; 5-period mean 1.42x, range 0.79x-2.30x.5.45x1.97x7.55x
Chart
  • HY24 Net debt / EBITDA: Outside range low net debt / ebitda. 4.4x; 3-period range 5.45x to 9.8x. Net debt / EBITDA: 4.40x, below normal range; 3-period mean 7.60x, range 5.45x-9.80x.
  • FY26 Net debt / EBITDA: Outside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.
Debtor days111—3—3-15Unprecedented highUnprecedented high debtor days. 5d; 5-period range 1d to 3d. Debtor days: 4.7 days, unprecedented high; 5-period mean 1.5 days, range 0.5 days-3.2 days.4
Chart
Inventory days665Outside range lowOutside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.6Outside range lowOutside range low inventory days. 6d; 3-period range 6d to 28d. Inventory days: 5.6 days, below normal range; 3-period mean 13.9 days, range 5.9 days-28.1 days.767810Unprecedented highUnprecedented high inventory days. 10d; 5-period range 5d to 7d. Inventory days: 10.4 days, unprecedented high; 5-period mean 6.2 days, range 5.3 days-7.4 days.28Outside range highOutside range high inventory days. 28d; 3-period range 6d to 8d. Inventory days: 28.1 days, above normal range; 3-period mean 6.4 days, range 5.6 days-7.8 days.
Chart
  • HY24 Inventory days: Outside range low inventory days. 6d; 3-period range 6d to 28d. Inventory days: 5.6 days, below normal range; 3-period mean 13.9 days, range 5.9 days-28.1 days.
  • FY24 Inventory days: Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.
Total assets$49.6m$51.6m$53.8m$56.7m$56.4m$54.9m$55m$59.6m$36.4m$42.1m
Chart

Reference: annolyse.ai/companies/svr

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...
  • HY21 SVR: Outside range low operating working-capital movement. $-8m; 3-period range $-1m to $0.2m. Operating working-capital movement: NZ$-8.0m, below normal range; 1/3 prior periods had builds averaging NZ$0.2m, and 1 had releases averaging NZ$-1.0m.
  • FY22 SVR: Outside range high operating working-capital movement. $0.2m; 5-period range $-3.4m to $0.1m. Operating working-capital movement: NZ$0.2m, above normal range; 1/5 prior periods had builds averaging NZ$0.1m, and 4 had releases averaging NZ$-1.8m.
  • FY23 SVR: Unprecedented low operating working-capital movement. $-3.4m; 5-period range $-3.1m to $0.2m. Operating working-capital movement: NZ$-3.4m, unprecedented low; 2/5 prior periods had builds averaging NZ$0.2m, and 3 had releases averaging NZ$-1.2m.
  • HY24 SVR: Outside range high operating working-capital movement. $0.2m; 3-period range $-8m to $0m. Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.

The setup & the reality

FY25 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

FY26 · Released 26 May 2026

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Read latest briefing→

Historical setup

What FY25 said to watch

From PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

No forward targets, FY26 guidance or forward-work disclosures are provided in this release, so the result cannot be benchmarked against management's own goals. The shape of the year is, however, distinctive: HY25 revenue was up over 40% on a depressed HY24 base, yet full-year revenue fell 8.4%, which implies H2 revenue of roughly $27.6m against an unusually strong H2 FY24. EBITDA was second-half weighted at the group level (H1 contributed only 43.2% of full-year EBITDA), so second-half profitability held up better than second-half revenue.

The gap that matters is the second-half revenue decline against last year's stronger comparable. The release attributes this to "reduced [activity per] head" but does not quantify volume, mix or pricing components, leaving the underlying demand trajectory into FY26 unclear.

Open questions

Open questions from FY25

  • What drove the second-half revenue decline against H2 FY24, and is the lower per-head spend a structural mix shift or a cyclical demand effect?
  • Why did the effective tax rate fall from 122.8% to 16.1%, and what is the expected normalised rate now that prior-year tax credits appear to have unwound?
  • How should investors read the 174.7% capex step-up to $1.3m – is this catch-up maintenance, new venue development, or the start of a sustained higher reinvestment level?
  • Why was no final dividend declared (payment date "Not Applicable") given the move to net cash, and what is the framework for resuming distributions?
  • Will the lower below-EBITDA cost base (D&A and finance costs roughly $3.0m lower year-on-year) persist, or does it reflect one-off items that won't repeat?

This briefing cannot assess the underlying volume, pricing and venue-level economics behind the second-half revenue decline because the release does not disclose them.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

FY26 · Released 26 May 2026

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Read briefing→

FY25 · Released 22 May 2025

PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

Revenue fell 8.4% and EBITDA dropped 17.2%, yet operating cash flow rose 10.9% as a smaller tax benefit drove NPAT into the red.

Read briefing→

FY24 · Released 22 May 2024

NPAT flipped positive on 122.7% tax rate while PBT loss widened 22.5%

EBITDA rose 68.1% on 18.1% revenue growth, but the headline profit reflects an unprecedented tax benefit rather than improvement at the pre-tax line.

Read briefing→

HY24 · Released 28 November 2023

EBITDA up 130% on 40.4% revenue growth, leverage halved to 4.4x

Operating leverage drove margin expansion and deleveraging, but the group remained loss-making and HY23 was only 26% of FY23 EBITDA.

Read briefing→

FY23 · Released 25 May 2023

Revenue up 180.2% drove turnaround, but $92.6m cash balance drained to zero

An unprecedented revenue rebound and a working-capital release shrank losses 93.9%, but equity fell 82.8% and the company carries new debt.

Read briefing→

HY23 · Released 23 November 2022

Leverage hit 9.8x EBITDA as margins compressed on a 20.7% revenue lift

Revenue rose 20.7% but EBITDA fell 33.6%, cash turned net negative and gearing moved well above the historical range as venue capex doubled.

Read briefing→

FY22 · Released 27 May 2022

Revenue up 89.5% on acquisition, but leverage hit an unprecedented 4.0x

Hipgroup lifted topline but EBITDA margin slipped to 9.8% and net debt/EBITDA reached 4.03x, while reported NPAT improvement reflects last year's

Read briefing→

HY22 · Released 18 November 2021

Acquisition lifted revenue 73.3% and tripled EBITDA, but loss widened 81.4%

The Hipgroup hospitality acquisition rebased Savor's top line and EBITDA above historical ranges, yet finance costs deepened the loss and lifted

Read briefing→

FY21 · Released 28 May 2021

Cash conversion collapsed to 0.7% as brewery exit drove FCF to -NZ$1.3m

Continuing-operations PBT improved 23.6% but operating cash fell 99.5% and FCF pre-lease turned negative despite a NZ$3.1m working-capital release.

Read briefing→

HY21 · Released 27 November 2020

Revenue down 45%; $8m working-capital release flatters cash

An issuer transition and prior-period acquisition leave the HY20 comparison non-comparable, while the working-capital release reflects contraction

Read briefing→

Related insights

Compare this company

The latest SVR metrics also appear in these cross-company views.

Insight

Cash conversion quality

This result converted 85.8% of EBITDA to operating cash flow, -11.9pp versus the prior comparable period.

Open insight→

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 16.8pp, with a distortion flag in the result.

Open insight→

Insight

Leverage and balance-sheet risk

Net debt / EBITDA is 0.79x, -0.20x versus the prior comparable period.

Open insight→

Insight

ROE and capital efficiency

ROE was 6.9%, +13.9pp versus the prior comparable period.

Open insight→

Get notified when SVR publishes

Get the next Savor result briefing and five-year history updates by email.